Andy Kaytes

In 1996, Andy began volunteering at Christie’s Place, an agency serving women, children, and families impacted by HIV/AIDS in San Diego.   This led to an interest in HIV and other types of medical research.  His past and current work has included treatment and research education, support group facilitation, and patient advocacy.  Since 2004, Andy has been an active member and currently co-chairs the Community Advisory Board at the University of California San Diego’s Antiviral Research Center.  As a member of the AIDS Clinical Trials Group (ACTG) Community Science Subcommittee of its Global Community Advisory Board, Andy represents the community on the HIV Reservoirs and Viral Eradication Transformative Science Group (Cure TSG), and the Neurology Collaborative Science Group and serves on several clinical trial teams.  With the AIDS Treatment Activists Coalition (ATAC) and its Drug Development Committee, Andy liaises with pharmaceutical companies, regulatory agencies, and academic institutions, advocating for ethical practices in clinical trials and adequate representation of key populations. Andy continues to serve on various other working groups and boards having to do with HIV, hepatitis, and other infectious disease research, treatment, and prevention.  

Conflict of Interest: Andy has reported having potential financial conflicts of interest within the past 12 months, or anticipated within the coming 12 months, with the following entities: Bristol Myers Squibb